High frequency oscillatory ventilation: initial experience in 22 patients

Area of Science:

• Neonatal Medicine
• Pediatric Critical Care
• Respiratory Physiology

Background:

• Conventional mechanical ventilation (CMV) can be insufficient for neonates with severe respiratory failure.
• High frequency oscillatory ventilation (HFOV) offers an alternative ventilatory strategy for critically ill neonates.
• Evaluating the outcomes of HFOV is crucial for optimizing neonatal respiratory support.

Purpose of the Study:

• To assess the in-hospital survival rate of neonates treated with HFOV.
• To identify and quantify comorbidities associated with HFOV in this cohort.
• To evaluate the acute changes in respiratory status following HFOV initiation.

Main Methods:

• Prospective cohort study of 22 neonates who failed conventional mechanical ventilation (CMV).
• Data collected on survival, patent ductus arteriosus (PDA), cerebroventricular haemorrhages (CVH), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and retinopathy of prematurity (ROP).
• Gestational age and acute respiratory status changes were also monitored.

Main Results:

• An 81.8% in-hospital survival rate was observed (18 of 22 neonates).
• Comorbidities included PDA (31.6%), CVH (36.8%), NEC (15.8%), BPD (66.7%), and ROP (66.7%) in survivors < 34 weeks gestation.
• Neonates >= 34 weeks gestation responded well with minimal comorbidity.

Conclusions:

• HFOV achieved an 81.8% survival rate in neonates with respiratory failure.
• Significant comorbidities, including BPD and ROP, were noted, especially in preterm infants.
• HFOV is a viable, though complex, ventilatory option for neonates requiring advanced respiratory support.